RNAi therapeutics in autoimmune disease

Pharmaceuticals

Volumn 6, Issue 3, 2013, Pages 287-294

  Pauley, Kaleb M ^a   Cha, Seunghee ^b  

^a CEDARVILLE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Autoimmune disease; microRNA; RNA interference; Small interfering RNA; Therapeutics

Indexed keywords

MICRORNA; MICRORNA 146A; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AUTOIMMUNE DISEASE; DRUG MECHANISM; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; NONHUMAN; OSTEOCLASTOGENESIS; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; RNA BINDING; RNA INTERFERENCE; RNA STABILITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84874989459     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph6030287     Document Type: Review

References (33)

1. Filipowicz, W.; Bhattacharyya, S.N.; Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet. 2008, 9, 102-114.
2. Meister, G.; Tuschl, T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004, 431, 343-349.
3. Vlassov, A.V.; Korba, B.; Farrar, K.; Mukerjee, S.; Seyhan, A.A.; Ilves, H.; Kaspar, R.L.; Leake, D.; Kazakov, S.A.; Johnston, B.H. ShRNAs targeting hepatitis C: Effects of sequence and structural features, and comparision with siRNA. Oligonucleotides 2007, 17, 223-236.
4. McAnuff, M.A.; Rettig, G.R.; Rice, K.G. Potency of siRNA versus shRNA mediated knockdown in vivo. J. Pharm. Sci. 2007, 96, 2922-2930.
5. Hughes, J.A.; Rao, G.A. Targeted polymers for gene delivery. Expert Opin. Drug Deliv. 2005, 2, 145-157.
6. Vorhies, J.S.; Nemunaitis, J.J. Nucleic Acid Aptamers for targeting of shRNA-based cancer therapeutics. Biologics 2007, 1, 367-376.
7. Kim, S.S.; Garg, H.; Joshi, A.; Manjunath, N. Strategies for Targeted Nonviral Delivery of siRNAs in vivo. Trends Mol. Med. 2009, 15, 491-500.
8. Love, T.M.; Moffett, H.F.; Novina, C.D. Not miR-ly small RNAs: Big potential for microRNAs in therapy. J. Allergy Clin. Immunol. 2008, 121, 309-319.
9. Schwarz, D.S.; Ding, H.; Kennington, L.; Moore, J.T.; Schelter, J.; Burchard, J.; Linsley, P.S.; Aronin, N.; Xu, Z.; Zamore, P.D. Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet. 2006, 2, e140.
10. Jackson, A.L.; Burchard, J.; Leake, D.; Reynolds, A.; Schelter, J.; Guo, J.; Johnson, J.M.; Lim, L.; Karpilow, J.; Nichols, K.; et al. Position-specific chemical modification of siRNAs reduces "off-target" Transcript Silencing. RNA 2006, 12, 1197-1205.
11. Layzer, J.M.; McCaffrey, A.P.; Tanner, A.K.; Huang, Z.; Kay, M.A.; Sullenger, B.A. In vivo activity of nuclease-resistant siRNAs. RNA 2004, 10, 766-771.
12. Choung, S.; Kim, Y.J.; Kim, S.; Park, H.O.; Choi, Y.C. Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem. Biophys. Res. Commun. 2006, 342, 919-927.
13. Wu, S.Y.; McMillan, N.A. Lipidic systems for in vivo siRNA delivery. AAPS J. 2009, 11, 639-652.
14. Hart, S.L. Multifunctional nanocomplexes for gene transfer and gene therapy. Cell Biol Toxicol 2010, 26, 69-81.
15. Mykhaylyk, O.; Zelphati, O.; Rosenecker, J.; Plank, C. SiRNA delivery by magnetofection. Curr. Opin. Mol. Ther. 2008, 10, 493-505.
16. Yu, B.; Zhao, X.; Lee, L.J.; Lee, R.J. Targeted delivery systems for oligonucleotide therapeutics. AAPS J. 2009, 11, 195-203.
17. Endoh, T.; Ohtsuki, T. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. Adv. Drug Deliv. Rev. 2009, 61, 704-709.
18. Lima, W.F.; Prakash, T.P.; Murray, H.M.; Kinberger, G.A.; Li, W.; Chappell, A.E.; Li, C.S.; Murray, S.F.; Gaus, H.; Seth, P.P.; et al. Single-stranded siRNAs activate RNAi in animals. Cell 2012, 150, 883-894.
19. Pauley, K.M.; Gauna, A.E.; Grichtchenko, I.I.; Chan, E.K.; Cha, S. A Secretagogue-small interfering RNA conjugate confers resistance to cytotoxicity in a cell model of Sjogren's syndrome. Arthritis Rheum. 2011, 63, 3116-3125.
20. Schiffelers, R.M.; Xu, J.; Storm, G.; Woodle, M.C.; Scaria, P.V. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum. 2005, 52, 1314-1318.
21. Khoury, M.; Louis-Plence, P.; Escriou, V.; Noel, D.; Largeau, C.; Cantos, C.; Scherman, D.; Jorgensen, C.; Apparailly, F. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum. 2006, 54, 1867-1877.
22. Komano, Y.; Yagi, N.; Onoue, I.; Kaneko, K.; Miyasaka, N.; Nanki, T. Arthritic joint-targeting small interfering RNA-encapsulated liposome: Implication for treatment strategy for rheumatoid arthritis. J. Pharmacol. Exp. Ther. 2012, 340, 109-113.
23. Chen, S.Y.; Shiau, A.L.; Li, Y.T.; Lin, Y.S.; Lee, C.H.; Wu, C.L.; Wang, C.R. Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of toll-like receptor 7 short hairpin RNA gene. Gene Ther. 2012, 19, 752-760.
24. Pauley, K.M.; Satoh, M.; Chan, A.L.; Bubb, M.R.; Reeves, W.H.; Chan, E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 2008, 10, R101.
25. Pauley, K.M.; Stewart, C.M.; Gauna, A.E.; Dupre, L.C.; Kuklani, R.; Chan, A.L.; Pauley, B.A.; Reeves, W.H.; Chan, E.K.; Cha, S. Altered miR-146a expression in Sjogren's syndrome and its functional role in innate immunity. Eur. J. Immunol. 2011, 41, 2029-2039.
26. Stanczyk, J.; Pedrioli, D.M.; Brentano, F.; Sanchez-Pernaute, O.; Kolling, C.; Gay, R.E.; Detmar, M.; Gay, S.; Kyburz, D. Altered expression of MICRORNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008, 58, 1001-1009.
27. Li, J.; Wan, Y.; Guo, Q.; Zou, L.; Zhang, J.; Fang, Y.; Fu, X.; Liu, H.; Lu, L.; Wu, Y. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res. Ther. 2010, 12, R81.
28. Nakasa, T.; Miyaki, S.; Okubo, A.; Hashimoto, M.; Nishida, K.; Ochi, M.; Asahara, H. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008, 58, 1284-1292.
29. Zilahi, E.; Tarr, T.; Papp, G.; Griger, Z.; Sipka, S.; Zeher, M. Increased microRNA-146a/b, TRAF6 Gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjogren's syndrome. Immunol. Lett. 2012, 141, 165-168.
30. Dai, Y.; Huang, Y.S.; Tang, M.; Lv, T.Y.; Hu, C.X.; Tan, Y.H.; Xu, Z.M.; Yin, Y.B. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16, 939-946.
31. Tang, Y.; Luo, X.; Cui, H.; Ni, X.; Yuan, M.; Guo, Y.; Huang, X.; Zhou, H.; de Vries, N.; Tak, P.P.; et al. MicroRNA-146A Contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009, 60, 1065-1075.
32. Luo, X.; Yang, W.; Ye, D.Q.; Cui, H.; Zhang, Y.; Hirankarn, N.; Qian, X.; Tang, Y.; Lau, Y.L.; de Vries, N.; et al. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 2011, 7, e1002128.
33. Nakasa, T.; Shibuya, H.; Nagata, Y.; Niimoto, T.; Ochi, M. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 2011, 63, 1582-1590.